Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546673 · ClinicalTrials.gov registry record · NA
Health Benefits of Expressive Writing: Study One
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT03546673 is a NA study that has completed, run by University of Houston. The registered enrollment target is 96 participants.
The verdict
NCT03546673, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
Interventions
- BEHAVIORAL Self-Regulation Condition
- BEHAVIORAL Emotional Disclosure Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03546673
The ClinicalTrials.gov registry entry for NCT03546673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self-Regulation Condition is the first listed.
NCT03546673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03546673 about?
NCT03546673 is a clinical study titled "Health Benefits of Expressive Writing: Study One". This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
What is the current status of trial NCT03546673?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2009-07. Estimated completion is 2011-10.
What interventions are being tested in trial NCT03546673?
The interventions under investigation include: Self-Regulation Condition (BEHAVIORAL), Emotional Disclosure Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03546673?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.